Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-13-000002

CEO bought 25,000 shares at $0.53 ($13,250)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Babcock Dwight William CEO 2013-11-01 Purchase +25,000 $0.53 $13,250 281,373 D
Open-market purchases · 25,000 sh · avg $0.53 · $13,250
Loading xslF345X03/primary_doc.xml…